Implications of Proposed Medicare Reforms to Counteract High Cancer Drug Prices. Article uri icon

Overview

publication date

  • July 19, 2016

Research

keywords

  • Antineoplastic Agents
  • Cost Control
  • Drug Costs
  • Medicare Part B

Identity

Scopus Document Identifier

  • 84978935158

Digital Object Identifier (DOI)

  • 10.1001/jama.2016.5998

PubMed ID

  • 27149663

Additional Document Info

volume

  • 316

issue

  • 3